Martin Shkreli Faces Legal Battle Over Wu-Tang Clan Album Allegations
Shkreli Accused of Improper Conduct with Once Upon a Time in Shaolin
Martin Shkreli, infamously known as Pharma Bro for dramatically increasing the price of the AIDS drug Daraprim, has found himself in legal trouble over the rare Wu-Tang Clan album. Recently, Judge Pamela Chen from the US District Court determined that Shkreli must contend with legal accusations concerning the alleged mishandling of intellectual property by duplicating and publicizing the exclusive album to his audience, effectively diminishing its rarity and worth.
Unusual Ownership Journey of the Album
A lawsuit initiated by PleasrDAO, a group associated with digital currencies, NFTs, and digital art ventures, is at the heart of these accusations. Shkreli originally bought this singular studio album back in 2015 for a whopping $2 million. However, following a conviction on fraud charges, his belongings, including the album, were confiscated, allowing PleasrDAO to purchase it through a government auction for $4 million.
Conditions and Allegations Heightening the Case
Apart from the album's inherent exclusiveness, it resides under a stipulation prohibiting 'commercial exploitation' by future owners for 88 years. The core argument from PleasrDAO arises from alleged admissions during Shkreli's live streams where he supposedly conceded to creating duplicates of the album and showcasing it to followers, even reportedly retorting 'LOL I have the mp3s you imbecile' to a PleasrDAO member who shared its photograph. Victory for PleasrDAO could compel Shkreli to relinquish all album copies and disclose information regarding duplicates, dissemination parties, and the revenue generated.



Leave a Reply